user

Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation

被引：0
|
作者：
Sharis M. Simonian
Shahram Lotfipour
Christopher Wall
Mark I. Langdorf
机构：
[1] University of California,Department of Emergency Medicine
[2] Irvine School of Medicine,Emergency Ultrasound
[3] University of California,undefined
[4] Irvine School of Medicine,undefined
[5] Hennepin County Medical Center,undefined
来源：
Internal and Emergency Medicine | 2010年 / 5卷
关键词：
Amiodarone; Procainamide; Wolff-Parkinson-White (WPW); Atrial fibrillation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF). The current recommendation for pharmacological treatment of this condition is amiodarone. A review of the past 25 years of literature finds several studies that identify a small risk of ventricular fibrillation secondary to amiodarone administration for rate control in WPW-AF. Additionally, the literature supports the safe and effective use of procainamide for rate control in WPW-AF. This review concludes that amiodarone is not superior to procainamide in rate control for WPW-AF, and may be dangerous.
引用
收藏
页码：421 / 426
页数：5
相关论文
共 50 条
  • [1] Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation
    Simonian, Sharis M.
    Lotfipour, Shahram
    Wall, Christopher
    Langdorf, Mark I.
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2010, 5 (05) : 421 - 426
  • [2] ACCELERATION OF VENTRICULAR RATE BY AMIODARONE IN ATRIAL-FIBRILLATION ASSOCIATED WITH THE WOLFF-PARKINSON-WHITE SYNDROME
    SHEINMAN, BD
    EVANS, T
    [J]. BRITISH MEDICAL JOURNAL, 1982, 285 (6347): : 999 - 1000
  • [3] Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation
    Boriani, G
    Biffi, M
    Frabetti, L
    Azzolini, U
    Sabbatani, P
    Bronzetti, G
    Capucci, A
    Magnani, B
    [J]. AMERICAN HEART JOURNAL, 1996, 131 (06) : 1214 - 1216
  • [4] The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome
    Ren, Jiameng
    Yang, Yanmin
    Zhu, Jun
    Wu, Shuang
    Wang, Juan
    Zhang, Han
    Shao, Xinghui
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (01): : 35 - 43
  • [5] ATRIAL-FIBRILLATION COMPLICATING WOLFF-PARKINSON-WHITE SYNDROME TREATED WITH AMIODARONE
    CHAMBERLAIN, DA
    CLARK, ANG
    [J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6101): : 1519 - 1520
  • [6] Safety of amiodarone usage in patients with Wolff-Parkinson-White syndrome and atrial fibrillation
    Kuzhel, D. A.
    Matyushin, G. V.
    Savchenko, E. A.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (03) : 359 - 362
  • [7] Is intravenous amiodarone safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome?
    Tijunelis, MA
    Herbert, ME
    [J]. ANNALS OF EMERGENCY MEDICINE, 2003, 42 (04) : S38 - S38
  • [8] Atrial fibrillation in a Wolff-Parkinson-White syndrome
    Guerisse, P.
    [J]. ANNALES FRANCAISES DE MEDECINE D URGENCE, 2013, 3 (01): : 48 - 49
  • [9] ATRIAL FIBRILLATION IN THE WOLFF-PARKINSON-WHITE SYNDROME
    Carmona Puerta, Raimundo
    Ramos Ramirez, Ramiro
    Padron Pena, Gustavo
    Napoles Lizano, Mario
    Satorre Igualada, Jesus A.
    Lopez Vega, Beatriz
    [J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2005, 34 (03): : 387 - 391
  • [10] The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome Response
    Ren, Jiameng
    Yang, Yanmin
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (03): : 568 - 568
12345